Pharmacokinetic Study of Deferiprone in Paediatric Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Chronic Iron Overload
Interventions
DRUG

Deferiprone, dose level 1

a solution at 80 mg/mL will be administered orally

DRUG

Deferiprone, dose level 2

a solution at 80 mg/mL will be administered orally

DRUG

Deferiprone, dose level 3

a solution at 80 mg/mL will be administered orally

Trial Locations (7)

35127

Azienda Ospedaliera Di Padova, Padua

70124

Azienda Ospedaliero-Universitaria Consorziale, Bari

80131

Azienda Ospedaliera Antonio Cardarelli, Napoli

90146

Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello, Palermo

Unknown

Department of Medical and Public Health Services of the Ministry of Health, Nicosia

Cairo Univesity Paediatric Hospital, Cairo

07100

Clinica Pediatrica Universita' - Asl 1, Sassari

All Listed Sponsors
collaborator

European Commission

OTHER

lead

Consorzio per Valutazioni Biologiche e Farmacologiche

OTHER

NCT01740713 - Pharmacokinetic Study of Deferiprone in Paediatric Patients | Biotech Hunter | Biotech Hunter